Sanofi India Limited
Bajaj Allianz Life Insurance increased its stake in Sanofi India from 1.37% to 1.44%, buying 15,000 additional shares. The value of its holding is now ₹113.2 Cr, based on the last closing price of ₹3414.20 per share.
A leading multinational pharmaceutical company operating in India, Sanofi India manufactures and distributes medicines across multiple therapeutic areas including diabetes, cardiology, thrombosis, central nervous system disorders, and anti-histamines. The company serves patients and healthcare providers through a comprehensive portfolio of pharmaceutical products designed to address diverse medical conditions. Its established presence in India's pharmaceutical market reflects its commitment to improving health outcomes across the country.
Now wholly owned by Bajaj Finserv after the Bajaj Group bought out Allianz SE's 26% stake in March 2025 for Rs 24,180 crore. Total AUM over Rs 1.2 lakh crore. Flagship Pure Stock Fund manages over Rs 7,200 crore as a Shariah-compliant Indian equity book. Active investor across large and midcap names through ULIP and group fund vehicles.